Atom Investors »

Enliven Therapeutics shares owned by Atom Investors

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Atom Investors from 13F filings

Historical chart of Atom Investors investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Atom Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Atom Investors

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.5M 50k 50.75

More positions owned by Atom Investors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Viatris (VTRS)
Intel Corporation (INTC)
Hewlett Packard Enterprise (HPE)
Rhythm Pharmaceuticals (RYTM)
Esab Corporation (ESAB)
Ishares Msci Brazil Etf (EWZ)
Gxo Logistics Incorporated Common Stock (GXO)
Applied Materials (AMAT)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
VSE Corporation (VSEC)
Apple (AAPL)
Immunome (IMNM)
John Bean Technologies Corporation (JBTM)

View all positions for Atom Investors

Top funds holding Enliven Therapeutics

FMR
OrbiMed Advisors
Polar Capital Holdings
BlackRock
Vestal Point Capital
Commodore Capital
Vanguard Capital Management
Citadel Advisors
Fairmount Funds Management
Siren
Bellevue Group
Geode Capital Management
First Light Asset Management
Pictet Asset Management Holding SA
State Street Corporation

View all funds holding Enliven Therapeutics